These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 17109715)

  • 21. Treatment of clozapine-associated tardive dyskinesia.
    Lin CC; Bai YM; Chen JY; Wang YC; Liou YJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):599-600. PubMed ID: 17920744
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacokinetics and safety of combination therapy with lithium and risperidone.
    Demling JH; Huang ML; Remmerie B; Mannaert E; Sperling W
    Pharmacopsychiatry; 2006 Nov; 39(6):230-1. PubMed ID: 17124646
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute dyskinesia on starting methylphenidate after risperidone withdrawal.
    Hollis CP; Thompson A
    Pediatr Neurol; 2007 Oct; 37(4):287-8. PubMed ID: 17903675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risperidone alone versus risperidone plus valproate in the treatment of patients with schizophrenia and hostility.
    Citrome L; Shope CB; Nolan KA; Czobor P; Volavka J
    Int Clin Psychopharmacol; 2007 Nov; 22(6):356-62. PubMed ID: 17917554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Choice of and decreasing of the dosage of risperidone in the treatment of schizophrenia. Global versus individual criteria.
    Gómez-Perretta C
    Actas Esp Psiquiatr; 2007; 35(1):77-8. PubMed ID: 17323229
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of ritanserin, a 5HT2A/2C antagonist, on negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.
    Akhondzadeh S; Malek-Hosseini M; Ghoreishi A; Raznahan M; Rezazadeh SA
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1879-83. PubMed ID: 18801405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risperidone-induced priapism.
    Makesar D; Thome J
    World J Biol Psychiatry; 2007; 8(1):45-7. PubMed ID: 17366350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sexual disinhibition in schizophrenia possibly induced by risperidone and quetiapine.
    Lam MH; Fong SY; Wing YK
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):333. PubMed ID: 17472606
    [No Abstract]   [Full Text] [Related]  

  • 29. Dysphagia: a rare form of dyskinesia?
    Nieves JE; Stack KM; Harrison ME; Gorman JM
    J Psychiatr Pract; 2007 May; 13(3):199-201. PubMed ID: 17522565
    [No Abstract]   [Full Text] [Related]  

  • 30. Pisa syndrome in a patient in a wheelchair taking valproic acid.
    Yohanan M; Aulakh JS; Weith J; Hawkins JW
    Am J Psychiatry; 2006 Feb; 163(2):325-6. PubMed ID: 16449491
    [No Abstract]   [Full Text] [Related]  

  • 31. Oral candidiasis secondary to adverse anticholinergic effects of psychotropic medications.
    Stevens HE
    J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):145-6. PubMed ID: 17343565
    [No Abstract]   [Full Text] [Related]  

  • 32. Tardive tremor.
    Storey E; Lloyd J
    Mov Disord; 1997 Sep; 12(5):808-10. PubMed ID: 9380072
    [No Abstract]   [Full Text] [Related]  

  • 33. Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: a randomized, open-label, controlled trial.
    Kim SW; Shin IS; Kim JM; Lee SH; Lee JH; Yoon BH; Yang SJ; Hwang MY; Yoon JS
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1504-9. PubMed ID: 17692448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Schizophrenia in a 5-year-old.
    Einfeld SL; Andrews D; Selig R; Williams G; Smith C
    Aust N Z J Psychiatry; 2005 Apr; 39(4):312. PubMed ID: 15777373
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of haloperidol and risperidone on cerebrohemodynamics in drug-naive schizophrenic patients.
    Lee SM; Chou YH; Li MH; Wan FJ; Yen MH
    J Psychiatr Res; 2008 Mar; 42(4):328-35. PubMed ID: 17412363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risperidone-associated increase in triglyceride levels.
    Weinbrenner A; Peus V; Inta D; Englisch S; Zink M
    Am J Psychiatry; 2009 Jan; 166(1):113-4. PubMed ID: 19122019
    [No Abstract]   [Full Text] [Related]  

  • 37. Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment.
    Lee BH; Kim YK
    Neuropsychobiology; 2009; 59(1):51-8. PubMed ID: 19270464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Risperidone use in child and adolescent psychiatric patients].
    Chevreuil C; Reymann JM; Frémaux T; Polard E; Séveno T; Bentué-Ferrer D
    Therapie; 2008; 63(5):359-75. PubMed ID: 19154706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time to rehospitalization of clozapine versus risperidone in the naturalistic treatment of comorbid alcohol use disorder and schizophrenia.
    Kim JH; Kim D; Marder SR
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):984-8. PubMed ID: 18262321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of risperidone on lipid profile.
    Khalili H; Dashti-Khavidaki S; Okhovatpour H; Ghaeli P
    Ann Pharmacother; 2007 May; 41(5):899-900. PubMed ID: 17426072
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.